A Study to Evaluate How Safe Pozelimab + Cemdisiran Combination Therapy is and How Well it Works in Adult Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) Who Have Not Recently Received or Have Not Received Complement Inhibitor Treatment
Clinical trial NCT05133531 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05133531
- Sponsor
- Regeneron Pharmaceuticals
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-01
- Primary completion
- 2026-10-12
- Enrollment
- 202
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.